
The Brugada Syndrome: From Bench to Bedside
Charles Antzelevitch(Editor)
Wiley (Publisher)
Published on 12. November 2007
Software
Other digital
248 pages
978-0-470-99490-0 (ISBN)
Description
Until recently, the cellular basis for sudden death, the Brugada Syndrome, has largely remained an unknown to modern arrhythmologists and cardiologists, particularly in the absence of any structural heart disease. Detailed observations of age-groups, especially the young, families and populations where sudden death frequently occurs, and improved understanding of its contributory factors and mechanisms are, however, showing the way forward. This addition to the Clinical Approaches to Tachyarrhythmias (CATA) Series, written by the investigators who discovered and probed the Brugada Syndrome, discusses the history, etiology, pathology and clinical manifestations of sudden death. From diagnosis, prognosis, to therapeutic approaches using the latest in cathater ablation techniques, electrophysiological surgery, and genetic appraisal, the work is a testimony to the author's investigation. Using clinical cases in Thailand and Laos, they further unravel the syndrome's molecular mechanisms, studying related syndromes, such as the long-QT syndrome, infant death, and arryhthmogenic right ventricular cardiomyopathy.
By being informed of the electrophysiological abnormalities that contribute to familial and genetic diseases, physicians, cardiologists and all those who care for patients with cardiac arrhythmias will be better able to identify and treat patients in whom the Brugada Syndrome may strike next.
By being informed of the electrophysiological abnormalities that contribute to familial and genetic diseases, physicians, cardiologists and all those who care for patients with cardiac arrhythmias will be better able to identify and treat patients in whom the Brugada Syndrome may strike next.
More details
Language
English
Place of publication
Hoboken
United Kingdom
Publishing group
John Wiley and Sons Ltd
Target group
Professional and scholarly
Dimensions
Height: 261 mm
Width: 183 mm
Thickness: 19 mm
Weight
742 gr
ISBN-13
978-0-470-99490-0 (9780470994900)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions

E-Book
05/2008
Wiley-Blackwell
€102.99
Available for download
Persons
Charles Antzelevitch, PhD, is Executive Director/Director of Research; Gordon K. Moe Scholar; Professor of Pharmacology at the Masonic Medical Research Laboratory; Utica, New York. Pedro Brugada, MD, PhD, is Professor of Cardiology at the Cardiovascular Center OLV Hospital in Aalst, Belgium.
Editor
Masonic Medical Research Laboratory; Utica, New York
Associate editor
Professor of Cardiology, Cardiovascular Research and Teaching Institute Aalst
University of Montreal
Content
Contributors. Preface. Dedication. 1 Brugada Syndrome: Overview. 2 History of the Brugada Syndrome. 3 Biophysical Analysis of Mutant Sodium Channels in Brugada Syndrome. 4 Molecular Genetics of the Brugada Syndrome. 5 Cellular Mechanisms Underlying the Brugada Syndrome. 6 Brugada Syndrome: Diagnostic Criteria. 7 Value of 12 Lead ECG and Derived Methodologies in the Diagnosis of Brugada Disease. 8 Brugada Syndrome: Relationship to Other Arrhythmogenic Syndromes. 9 ST Segment Elevation and Sudden Death in the Athlete. 10 Brugada Syndrome Genetics. Genetic Screening- Role in Diagnosis. 11 Genotype-Phenotype Relationship in Brugada Syndrome. 12 Gender Differences in Brugada Syndrome. 13 Predisposing Factors. 14 Acquired Forms of Brugada Syndrome. 15 Brugada Syndrome and supraventricular tacharrhythmias. 16 Prognosis in Individuals with the Brugada Syndrome. 17 Treatment of the Brugada Syndrome with the Implantable Cardioverter Defibrillator. 18 Pharmacologic Approach to Therapy of the Brugada Syndrome: Quinidine as an Alterative to ICD Therapy?. 19 Potential for Ablation Therapy in Patients with the Brugada Syndrome. Index